期刊文献+

通用引物PCR法在人乳头瘤病毒基因检测中的应用 被引量:2

Application of General Primer PCR for Detection of HPV L1 gene
下载PDF
导出
摘要 目的建立通用引物PCR法检测人乳头瘤病毒(HPV)基因的方法,探讨其在临床辅助诊断中的应用。方法收集787份标本,其中来自男性160份,女性标本627份。标本均使用通用引物对MY11/09扩增HPVL1基因片段。同时扩增β球蛋白(β-globin)基因作为内对照。结果787份标本中,191份标本HPVL1基因阳性,阳性率为24.3%。男性20~岁组HPV的检出率最高,女性30~岁组HPV的检出率最高,但均无年龄上的显著性差异。患有性病(淋病、尖锐湿疣)、不孕症、宫颈炎、非淋菌性阴道炎等疾病的女性,HPVL1基因的检出率分别为83.3%、20.9%、22.7%、28.0%。男性性病(淋病、尖锐湿疣)、前列腺炎、非淋菌性尿道炎、不育症患者的HPVL1基因检出率分别为42.9%、18.9%、12.5%、7.8%。结论HPVL1基因的检出率较高。通用引物PCR法在临床检验中具有较高的敏感性和特异性。 Objective To study the advantages of the MY11/09 PCR in HPV L1 gene detection and the application in the clinic. Methods 787 samples including 160 male and 627 female samples were collected HPV L1 and β-globin genes of all the samples were amplified simultaneously. Results 191 samples out of 787 were HPV L1 gene positive and the positive rate was 24.3%. The highest male HPV L1 gene positive rate was in the age group of 20-,and the female highest HPV L1 gene positive rate was in the age group of 30-,but the differences were not significant. HPV L1 has been detected from patients suffering from some genital diseases, such as colpitis, urethritis, prostatitis, sterility, cervical and cutaneous warts. Conclusions HPV infection is related to some genital diseases. General primer MY11/09 PCR is sensitive and specific for detection of HPV L1 gene in the clinic.
出处 《海南医学》 CAS 2007年第8期49-51,共3页 Hainan Medical Journal
基金 海南省自然科学基金资助项目 编号:30467
关键词 HPV 通用引物 PCR HPV General Primer PCR
  • 相关文献

参考文献9

二级参考文献38

  • 1Denny L, Kuhn L, Pollack A, et al. Direct visual inspection for cervical cancer screening: an analysis of factors influencing test performance. Cancer, 2002,94(6): 1699-1707.
  • 2Patnick J. Cevical cancer control in Europe. CME J Gynecol Oncol,2000,5:8-11.
  • 3Harper DM, Noll WW, Belloni DR, et al. Randomized clinical trial of PCB--determined human papillomavirus detection methods: selfsampling versus clinician-directed-biologic concordance and women's preferences. Am J Obstet Gynecol, 2002,186(3):365-373.
  • 4Mandelblatt JS, Lawrence WF, Womack SM, et al. Benefits and costs of using HPV testing to screen for cervical cancer. JAMA,2002, 287(18):2372-2381.
  • 5Heley S. Human papillomavims: beware the infection you can't see.Aust Faro Physician, 2003,32(5):311-315.
  • 6Berhard Kleter, Leen-Jan van Doom,Jan ter Schegget,et al. Novel Short Fragment PCR Assay for Highly Sensitive Broad-Spectrum Detection of Anogenital Human Papillomaviruses. Am J Pathol,1998,153(6):1731-1739.
  • 7van Den Brule AJ, Pol R, Fransen-Daalmeijer N, et al. GPS+/6+ PCR followed by Reverse Line Blot Analysis Enables Rapid and High-Throughput Identification of Human Papillomavirus Genotypes. J Clin Microbiol,2002,40(3):779-787.
  • 8Pretofius RG, Peterson P, Novak S, et al. Comparison of two signalamplification DNA tests for high-risk HPV as an aid to colposcopy. J Reprod Med, 2002,47(4):290-296.
  • 9Jason DW, Thomas JH. Human papillomavirus: Emerging Trends in Detection and Management. Current Women's Health Reports, 2002,2:259-265.
  • 10Denise Zielinski G, Snijders PJ, Rozendaal L, et al. High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance. J Pathol,2001,195(3):300-306.

共引文献43

同被引文献48

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部